Junyi Li

No. 1168, Chunrong West Road, Yuhua Street, Chenggong District
Kunming, 650500, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Correction: METTL3 accelerates staphylococcal protein A (SpA)-induced osteomyelitis progression by regulating m6A methylation-modified miR-320a.

Correction: METTL3 accelerates staphylococcal protein A (SpA)-induced osteomyelitis progression by regulating m6A methylation-modified miR-320a.

Journal: Journal of orthopaedic surgery and research

Published: March 28, 2026

Correction: METTL3 accelerates staphylococcal protein A (SpA)-induced osteomyelitis progression by regulating m6A methylation-modified miR-320a.

Correction: METTL3 accelerates staphylococcal protein A (SpA)-induced osteomyelitis progression by regulating m6A methylation-modified miR-320a.

Journal: Journal of orthopaedic surgery and research

Published: March 18, 2026

Optimizing the osteo-immunomodulatory balance: threshold-saturation effects of BMP-2-loaded allografts in the Masquelet's induced membrane technique (MIMT).

Optimizing the osteo-immunomodulatory balance: threshold-saturation effects of BMP-2-loaded allografts in the Masquelet's induced membrane technique (MIMT).

Journal: Frontiers in bioengineering and biotechnology

Published: February 27, 2026

LncRNA PVT1 activates HIF-1α/RANKL signal to promote osteoclast differentiation and inflammatory response through post-transcriptional regulation.

LncRNA PVT1 activates HIF-1α/RANKL signal to promote osteoclast differentiation and inflammatory response through post-transcriptional regulation.

Journal: Biochimica et biophysica acta. Molecular cell research

Published: May 26, 2025

FTO-engineered extracellular vesicles from bone marrow mesenchymal stem cells ameliorate Staphylococcus aureus-induced osteomyelitis via m6A-dependent suppression of autophagy and pyroptosis.

FTO-engineered extracellular vesicles from bone marrow mesenchymal stem cells ameliorate Staphylococcus aureus-induced osteomyelitis via m6A-dependent suppression of autophagy and pyroptosis.

Journal: Journal of biological engineering

Published: April 18, 2025

A comprehensive review of pathology and treatment of staphylococcus aureus osteomyelitis.

A comprehensive review of pathology and treatment of staphylococcus aureus osteomyelitis.

Journal: Clinical and experimental medicine

Published: December 04, 2024

METTL3 accelerates staphylococcal protein A (SpA)-induced osteomyelitis progression by regulating m6A methylation-modified miR-320a.

METTL3 accelerates staphylococcal protein A (SpA)-induced osteomyelitis progression by regulating m6A methylation-modified miR-320a.

Journal: Journal of orthopaedic surgery and research

Published: June 19, 2024

N6 methyladenosine eraser FTO suppresses Staphylococcus aureus-induced ferroptosis of bone marrow mesenchymal stem cells to ameliorate osteomyelitis through regulating the MDM2/TLR4/SLC7A11 signaling pathway.

N6 methyladenosine eraser FTO suppresses Staphylococcus aureus-induced ferroptosis of bone marrow mesenchymal stem cells to ameliorate osteomyelitis through regulating the MDM2/TLR4/SLC7A11 signaling pathway.

Journal: Cell biology international

Published: August 14, 2023

DNMT1-mediated DNA methylation in toll-like receptor 4 (TLR4) inactivates NF-κB signal pathway-triggered pyroptotic cell death and cellular inflammation to ameliorate lipopolysaccharides (LPS)-induced osteomyelitis.

DNMT1-mediated DNA methylation in toll-like receptor 4 (TLR4) inactivates NF-κB signal pathway-triggered pyroptotic cell death and cellular inflammation to ameliorate lipopolysaccharides (LPS)-induced osteomyelitis.

Journal: Molecular and cellular probes

Published: April 22, 2023

Showing 1-9 of 9

Last Updated: 09/26/2026